Clinical trial · Interventional
A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma
NCT00825474CI-TRIAL-00021592completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Presently,the diagnostic method of small hepatocellular carcinoma has been greatly elevated in China.The treatment is being from simplification to diversification,from entirety to individualization.Confronting small hepatocellular carcinoma,we not select simple operation treatment but select a treatment that have more predominance and more fitting with patients in various kinds of treatment methods;including operation ,TACE,PEI,et al.which is better ? There are many arguments.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| operation;TACE plus PEI | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- survival rate
- description
- therapeutic effect of partial hepatectomy or TACE plus PEI for small hepatocellular carcinoma
- interventionNames
- Other: operation;TACE plus PEI
Primary outcomes (1)
- measure
- overall survival
- timeFrame
- 2010
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. via clinical diagnosis and confirm it is primary liver cancer, and not accept any anticancer treatment. 2. age:18-70years 3. early hepatocyte cancer，which is single focus of infection diameter ≤3cm. 4. estimate tumor can gain treatment of curing operation or micro-create treatment combineation 5. better liver function (Child-Pugh，class A or B) Exclusion Criteria: 1. reject to attend； 2. impossible to come to our hospital for physical examination regularly. 3. cancer epitome、seed focus、lymph node or distant metastasis 4. Blood clotting function hindrance; 5. serious heart、lung、kidney disease.
References
Publications (0)
Data not yet available
No reference posted for this study.